In colorectal cancer (CRC), mutations in the PIK3CA gene, which encodes for the p100α subunit of PI3K, lead to upregulation of GPT2 and reliance on glutamine-derived TCA intermediates to sustain growth [32]. The gene discussed is PIK3CA; the disease is colorectal carcinoma.